1/23
Comprehensive vocabulary flashcards covering the neurobiology, sleep regulation processes, diagnostics, sleep-wake disorders, and pharmacological and non-pharmacological treatments from Week 9 Psychopharmacology lecture notes.
Process C (Circadian Rhythm)
The endogenous biological clock that governs physiological and behavioral rhythms across an approximate 24-hour cycle ("circa diem"), entrained by light and dark cues via the suprachiasmatic nucleus (SCN) of the hypothalamus.
Process S (Homeostatic Sleep Drive)
The physiological mechanism that tracks time spent awake and builds sleep pressure through the breakdown of ATP and accumulation of adenosine, which progressively dissipates during sleep.
Process U (Ultradian Cycle)
A biological rhythm that recurs multiple times within a 24-hour day with a period shorter than 24 hours (typically 90 to 120 minutes), governing the internal architecture of sleep stages and daytime focus fluctuations.
Basic Rest-Activity Cycle (BRAC)
A recurring daytime ultradian rhythm in which brain activity shifts between approximately 90 minutes of high focus and alertness and 20 minutes of natural fatigue or recovery need.
NREM Stage 3 Sleep
Deep, slow-wave sleep characterized by delta waves that lasts 20 to 40 minutes per cycle and comprises approximately 20% of total sleep, crucial for physical repair, growth, immune function, and memory consolidation.
Disorders of Arousal (DoA)
A cluster of NREM parasomnias occurring during slow-wave sleep (N3) caused by a dissociation between sleep and wakefulness, wherein motor and limbic structures activate into wakefulness while associative cortices remain in deep slow-wave sleep.
Confusional Arousals
An arousal disorder typically occurring in the first third of the night upon partial awakening from deep NREM sleep, characterized by disorientation, slow or incoherent speech, a glassy stare, and subsequent morning amnesia.
Somnambulism (Sleepwalking)
A parasomnia involving complex motor behaviors performed during deep slow-wave sleep, ranging from walking to leaving the house, accompanied by a blank facial expression and complete lack of memory of the event.
Sleep Terrors (Pavor Nocturnus)
Intense arousal parasomnias characterized by sudden screaming, extreme agitation, and massive sympathetic autonomic activation (tachycardia, diaphoresis, dilated pupils) during slow-wave sleep, ending with rapid re-entry into sleep and amnesia.
Thalamic Gating
The regulatory process mediated by the reticular thalamic nucleus (TRN) and thalamocortical loops that controls external sensory transmission to the cerebral cortex across states of arousal.
Reticular Thalamic Nucleus (TRN)
A nucleus that hyperpolarizes thalamic relay neurons during sleep, generating delta waves and sleep spindles (11 to 15 Hz) to create a partial sensory gate that protects sleep continuity.
Polysomnography (PSG)
The gold-standard overnight laboratory diagnostic test that records electroencephalogram (EEG), electrooculogram (EOG), electrocardiogram (ECG), respiration, pulse oximetry, and electromyogram (EMG).
Multiple Sleep Latency Test (MSLT)
A daytime evaluation comprising 5 scheduled naps spaced across the day to measure objective sleepiness; a mean sleep latency of <8 minutes paired with two or more Sleep-Onset REM Periods (SOREMs) indicates narcolepsy.
Actigraphy
An objective physiological monitoring method using a wrist-worn motion accelerometer over 1 to 2 weeks to record rest-activity patterns and estimate sleep parameters in a home environment.
Orexin (Hypocretin)
A wake-promoting neuropeptide produced exclusively in the lateral hypothalamus that stabilizes the Ascending Reticular Activating System (ARAS); its loss causes the fragmented state transitions of Narcolepsy Type 1.
Ventrolateral Preoptic Nucleus (VLPO)
A sleep-active hypothalamic region containing inhibitory neurons that release GABA and galanin to suppress wake-promoting nuclei in the brainstem and hypothalamus.
Flip-Flop Switch Model
A circuit model of sleep regulation where the sleep-promoting VLPO and wake-promoting ARAS mutually inhibit each other to produce rapid, distinct state transitions without intermediate stages.
Z-Drugs (Non-Benzodiazepines)
GABA-A receptor agonists (e.g., zolpidem, zopiclone, zaleplon) that selectively target the α1 subunit, delivering targeted sedative-hypnotic effects while preserving slow-wave and REM sleep architecture.
Dual Orexin Receptor Antagonists (DORAs)
A medication class (e.g., suvorexant, lemborexant, daridorexant) that facilitates sleep onset and maintenance by selectively blocking endogenous orexin-mediated wakefulness signals without globally suppressing cortical activity.
Eugeroics
Wakefulness-promoting medications (e.g., modafinil, armodafinil) that act as weak dopamine reuptake inhibitors to enhance daytime alertness with minimal peripheral autonomic stimulation.
Pitolisant
A wake-promoting agent that acts as a selective histamine H3 receptor antagonist and inverse agonist, disinhibiting presynaptic autoreceptors to increase endogenous histamine release in the brain.
Oxybates (Sodium Oxybate / Calcium Oxybate)
Nighttime-administered therapeutic agents that consolidate slow-wave sleep, clinically indicated to reduce daytime sleepiness and cataplexy attacks in patients with narcolepsy.
Stimulus Control Therapy
A core CBT-I component aimed at breaking conditioned wakefulness and performance anxiety by instructing patients to get out of bed whenever they have been awake for 15 to 20 minutes.
Sleep Restriction Therapy
A behavioral technique within CBT-I that restricts total time spent in bed to equal the patient's actual baseline sleep duration, systematically increasing homeostatic sleep pressure.